The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves discusses topics across the investing world.
Johnson & Johnson is one of the great American companies of all time -- we, of course, immediately think of Band-Aids and baby powder, but maybe don't realize its dominant position across a lot of health care segments. It recently raised its yield by 7%, which means it's hiked its payout every year for the past 50 years. That compares well to Procter & Gamble, which has done it for 56 years. Johnson & Johnson's yield is 3.84%, which compares to 3.1% for the Dow as a whole. That puts it in the neighborhood of big pharma stocks Merck and Pfizer, which both yield over 4%. With JNJ you have a high yield and a strong business. And Morningstar thinks its drug pipeline is extremely strong. Some product recalls have hurt its traditionally excellent reputation, but John still likes this one over the long-term.
Johnson & Johnson is one of the finest dividend stocks out there. If you'd like to learn about some additional dividend-payers, The Motley Fool has compiled a special free report outlining our top nine dependable, dividend-paying stocks. It's called "Secure Your Future With 9 Rock-Solid Dividend Stocks." You can access your copy today at no cost! Just click here to discover the winners we've picked.
